On July 30, 2011, we learned that the JFDA decided not to approve the protocol for our Jordanian study of MDMA-assisted psychotherapy for PTSD at this time, based in part on comments from an expert reviewer chosen by the JFDA. We anticipate receiving a further set of questions from JFDA soon, and we are hopeful this study will eventually be approved.